Literature DB >> 19486345

Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy?

Alessandro Cucchetti1, Marco Vivarelli, Matteo Ravaioli, Matteo Cescon, Giorgio Ercolani, Fabio Piscaglia, Massimo Del Gaudio, Gian Luca Grazi, Lorenza Ridolfi, Antonio Daniele Pinna.   

Abstract

BACKGROUND: Macrovesicular steatosis of the liver is associated with early dysfunction or poor function of the graft after transplantation; however, it can be quantified accurately only through a liver biopsy that sometimes may not be available and whose result is anyway known when the recipient has already been selected. It would, therefore, be helpful to be able to predict the degree of steatosis, on the basis of non-invasive readily available variables.
METHODS: Data from 374 deceased liver donors from whom a liver biopsy had been taken were analyzed with the receiver operating characteristic area [area under the curve (AUC)] to identify variables that could predict the degree of macrovesicular steatosis classified as: absent to mild (0-30%) and moderate to severe (>30%).
RESULTS: Steatosis was associated significantly with donor age, increased body mass index (BMI), presence of type II diabetes, ultrasonographic features, heavy alcohol consumption, transaminases [aspartate-aminotransferase and alanine-aminotransferase (ALT)], gamma-glutamyl-transpeptidase, and glucose blood levels. The combination of BMI, elevation of ALT, presence of type II diabetes, history of heavy alcohol consumption, and ultrasonography signs of steatosis could identify steatosis >30% accurately with an AUC of 0.86 (95% CI = 0.81-0.91).
CONCLUSION: Fatty infiltration in liver donors can be estimated based on clinical and biochemical parameters.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486345     DOI: 10.1111/j.1399-0012.2009.00987.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

Review 1.  Using old liver grafts for liver transplantation: where are the limits?

Authors:  Carlos Jiménez-Romero; Oscar Caso Maestro; Félix Cambra Molero; Iago Justo Alonso; Cristina Alegre Torrado; Alejandro Manrique Municio; Jorge Calvo Pulido; Carmelo Loinaz Segurola; Enrique Moreno González
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model.

Authors:  Ming Zhang; Fei Yin; Bo Chen; You Ping Li; Lu Nan Yan; Tian Fu Wen; Bo Li
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

3.  Liver biopsy may facilitate pancreatic graft evaluation: Positive association between liver steatosis and pancreatic graft adipose infiltration.

Authors:  Lucas S Nacif; Vinicius Rocha-Santos; Laura C L Claro; Agustin Vintimilla; Leandro A Ferreira; Rubens M Arantes; Rafael S Pinheiro; Wellington Andraus; Venancio A F Alves; Luiz Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2018-05-28       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.